Papers
1
Total Citations
14
H-Index
1
About
Gianmauro Numico is a leading oncologist whose research focuses on optimizing treatment strategies for gastrointestinal cancers, particularly rectal cancer. His major contributions center on refining the timing of surgery following neoadjuvant chemoradiotherapy, a critical question in improving patient outcomes. Numico’s most cited work, the TiMiSNAR trial (2019), is a landmark multicenter randomized controlled trial that compared standard 8-week versus prolonged 12-week intervals to minimally-invasive surgery after chemoradiation. This study challenged conventional timelines by investigating whether delayed surgery could enhance tumor regression and increase pathologic complete response rates, directly impacting clinical guidelines. With 14 citations, this paper underscores his influence in surgical oncology. Numico’s research has shaped debates on personalized treatment sequencing, balancing tumor response with surgical risks. His work is notable for its rigorous methodology and direct translational relevance, offering evidence to guide clinicians in tailoring care. For students and researchers, Numico exemplifies how targeted clinical trials can resolve longstanding controversies, advancing precision in cancer management.
Research Focus
Key Achievements
Top Papers
- 1